Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT05322226
NA

Addiction Intervention in Liver Transplantation Candidates

Sponsor: University Hospital, Montpellier

View on ClinicalTrials.gov

Summary

Addiction care is "a la carte treatment", adapted to the motivation and time constrains of users. Thus, various types of psychotherapeutic follow-up can be considered, different addictolytic medications or opioid maintenance therapies can be offered during treatment and hospitalization must be adaptable. In liver transplantation (LT), sustained alcohol relapse is a critical issue because it increases medium and long-term morbidity and mortality. In recent years, the issue of severe acute alcoholic hepatitis as an indication for LT has necessitated increased focus on appropriate alcohol monitoring around liver transplantation. Previously, alcohol consumption in pre- and post-LT period was mainly self-reported. More recently, the biological markers of excessive alcohol consumption have been validated in liver disease and can play a role in liver transplant recipients follow-up. The investigator hypothesize that standardized targeted addiction monitoring of LT patients decreases the rates of sustained alcohol relapse one year post liver transplantation.

Official title: Evaluation of an Addiction Intervention in Candidates for Liver Transplantation

Key Details

Gender

All

Age Range

18 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

64

Start Date

2022-07-27

Completion Date

2026-12-31

Last Updated

2025-12-03

Healthy Volunteers

No

Interventions

BEHAVIORAL

Addiction follow-up before and after liver transplantation

Addiction consult and follow-up

Locations (1)

Department of hepato-gastroenterology and liver transplantation

Montpellier, Occitanie, France